Stay updated with breaking news from Mikhail papisov. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MRSN | Mersana Therapeutics Inc. Stock Overview (U.S.: Nasdaq) barrons.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from barrons.com Daily Mail and Mail on Sunday newspapers.
Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Rating) – Equities researchers at Wedbush boosted their Q2 2024 earnings per share (EPS) estimates for Mersana Therapeutics in a research note issued on Thursday, June 15th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings of ($0.40) per share for the quarter, up from their […] ....
Mersana Therapeutics (NASDAQ:MRSN – Get Rating) had its target price decreased by Robert W. Baird from $20.00 to $7.00 in a research note published on Friday morning, The Fly reports. Other research analysts also recently issued reports about the stock. BTIG Research cut their price target on shares of Mersana Therapeutics from $16.00 to $10.00 […] ....
Mersana Therapeutics (NASDAQ:MRSN – Get Rating) had its price objective cut by BTIG Research from $16.00 to $10.00 in a report issued on Thursday, The Fly reports. Several other brokerages have also recently weighed in on MRSN. JPMorgan Chase & Co. raised Mersana Therapeutics from a neutral rating to an overweight rating and set a […] ....
JPMorgan Chase & Co. downgraded shares of Mersana Therapeutics (NASDAQ:MRSN – Get Rating) from an overweight rating to a neutral rating in a report released on Thursday morning, The Fly reports. They currently have $5.00 price objective on the stock, down from their previous price objective of $11.00. Other analysts also recently issued research reports […] ....